Kiniksa Pharmaceuticals International, plc (KNSA)

Market price: $90.21

6 valuation methods

• P / E: $19.38 to $81.94 (midpoint $27.53)
• EV / EBITDA: $26.64 to $73.51 (midpoint $37.31)
• P / B: $30.34 to $81.28 (midpoint $45.81)
• EV / Revenue: $38.68 to $78.97 (midpoint $53.32)
• DCF (FCFF): $64.53 to $88.49 (midpoint $74.58)
• EV / Gross Profit: $60.55 to $118.11 (midpoint $84.11)